NCT03120299View on ClinicalTrials.gov

The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)

PHASE4CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

March 1, 2021

Study Completion Date

June 1, 2021

Conditions
Type 2 Diabetes MellitusHypertriglyceridemia
Interventions
DRUG

Omega-3 fatty acid

Omega-3 fatty acids capsules, 1 gram gel capsule, 2 capsules orally administered twice a day for 12 weeks

DRUG

Placebos

Matching placebo capsules, 1 gram gel capsule, 2 capsules orally administered twice a day for 12 weeks

Trial Locations (1)

200025

Ruijin hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT03120299 - The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN) | Biotech Hunter | Biotech Hunter